Fetal and neonatal alloimmune thrombocytopenia
MONDO:0019415A rare hematological disease characterized by maternal alloimmunisation against fetal platelet antigens that are inherited from the father and different from those present in the mother, and usually presents as a severe isolated thrombocytopenia in otherwise healthy newborns.
Also known as: NAIT
11 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New blood product could cut transfusions in major surgeries
Disease control CompletedThis study tested a pathogen-reduced version of cryoprecipitate, a blood product that helps blood clot, in 208 patients undergoing liver transplant or heart surgery. The goal was to see if having this product readily available could stop bleeding early and reduce the need for oth…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Large study tracks antibody risk in pregnant women to prevent newborn bleeding
Knowledge-focused CompletedThis study followed over 14,000 pregnant women to see how many are at risk for a condition called FNAIT, where a mother's immune system attacks her baby's platelets, causing dangerous bleeding. Researchers measured how often women develop specific antibodies (HPA-1a) and looked a…
Sponsor: Rallybio • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC